Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

162.50
-0.2050-0.13%
Volume:1.05M
Turnover:171.60M
Market Cap:252.03B
PE:24.33
High:163.75
Open:162.86
Low:161.96
Close:162.70
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.87
T/O Rate:0.07%
Dividend:3.23
Dividend Rate:1.99%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.01
PE(LYR):24.85

Loading ...

AstraZeneca Upbeat Internal Pipeline Can Drive Growth Beyond 2030

Dow Jones
·
Jul 28

AstraZeneca (AZN) Gets a Buy from Barclays

TIPRANKS
·
Jul 28

Goldman Sachs Reaffirms Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Jul 28

AstraZeneca Beats Q2 Core Earnings Forecast, Reaffirms $80 Billion Revenue Goal for 2030

Deep News
·
Jul 28

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 28

Top Midday Stories: Nvidia Enters Into $500 Billion Partnership With SK Group; AstraZeneca Earnings Top Estimates

MT Newswires Live
·
Jul 27

AstraZeneca Posts 6% Revenue Growth in First Half, Maintains Full-Year Forecast

Deep News
·
Jul 27

AstraZeneca miss ‘clear positive’ for Omeros, says H.C. Wainwright

TIPRANKS
·
Jul 27

Omeros up 11% to $10.89 after AstraZeneca study failure

TIPRANKS
·
Jul 27

AstraZeneca's Sone-Ve Significantly Extends Overall Survival in Late-Stage Gastric Cancer Phase III Trial

Deep News
·
Jul 27

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as Oil Prices Fall

MT Newswires Live
·
Jul 27

Sector Update: Healthcare

MT Newswires Live
·
Jul 27

Pipeline Speed Bump Doesn't Shake AstraZeneca's $80 Billion Revenue Ambition

Benzinga Earnings
·
Jul 27

AstraZeneca Sees Potential for AI Beyond Drug Discovery

Dow Jones
·
Jul 27

AstraZeneca Wants to Move at 'Chinese Speed,' CEO Says

Dow Jones
·
Jul 27

Europe Faces Competition for Pharma Investment, AstraZeneca CEO Says

Dow Jones
·
Jul 27

Europe, Japan are Falling Behind on Pharma Innovation, AstraZeneca CEO Says

Dow Jones
·
Jul 27

AstraZeneca Sees 2030 Goal on Track as Cancer Drugs Drive Growth

Dow Jones
·
Jul 27

Press Release: AstraZeneca Results: H1 and Q2 2026

Dow Jones
·
Jul 27

AstraZeneca ‘on track’ to deliver ambition of $80B in revenue in 2030

TIPRANKS
·
Jul 27